1-Methyl Emodin

CAS No. 3775-08-4

1-Methyl Emodin( ——— )

Catalog No. M38878 CAS No. 3775-08-4

1-O-Methylemodin is a nature product that could be isolated from Zopfiella longicaudata. 1-O-Methylemodin has antifungal activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1-Methyl Emodin
  • Note
    Research use only, not for human use.
  • Brief Description
    1-O-Methylemodin is a nature product that could be isolated from Zopfiella longicaudata. 1-O-Methylemodin has antifungal activity.
  • Description
    1-O-Methylemodin is a nature product that could be isolated from Zopfiella longicaudata. 1-O-Methylemodin has antifungal activity.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    3775-08-4
  • Formula Weight
    284.26
  • Molecular Formula
    C16H12O5
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xue Y, et, al. Characterization and Structural Analysis of Emodin-O-Methyltransferase from Aspergillus terreus. J Agric Food Chem. 2022 May 11;70(18):5728-5737.?
molnova catalog
related products
  • Nitrofen

    Nitrofen is a selective contact herbicide. Nitrofen is a retinal dehydrogenase and protoporphyrinogen oxidase inhibitor.

  • Iristectorin A-6-O-g...

    The herbs of Iris tectorum.

  • 3-Hydroxybenzoic aci...

    Produced in the gut microflora as one of the three main metabolites formed from the catechin diet. Its use in the production of glycol benzoates for the application of plasticizer in adhesive formulations is increasing.